Clinical Trial: A GBT021601 ADME Microtracer Study in Healthy Volunteers
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Condition: Sickle Cell Disease
Study Type: Interventional
Official Title: A Phase 1 Study To Assess the Mass Balance, Excretion, and Pharmacokinetics of [14C]-GBT021601, An Oral Hemoglobin S Polymerization Inhibitor, in Healthy Participants
Brief Summary:
An Open-label Study of GBT021601 in 8 to 10 healthy male or female participants to evaluate the absorption, distribution, metabolism, and excretion (ADME) of GBT021601.
Read more